GAO-17-564, INVESTIGATIONAL NEW DRUGS:: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify Ho
![WEP Clinical on X: "Find out more about the FDA Expanded Access Programs https://t.co/e0Hz6g7zL2 https://t.co/0MioyEACpr" / X WEP Clinical on X: "Find out more about the FDA Expanded Access Programs https://t.co/e0Hz6g7zL2 https://t.co/0MioyEACpr" / X](https://pbs.twimg.com/media/DTDJPkFXUAM4xWU.jpg)
WEP Clinical on X: "Find out more about the FDA Expanded Access Programs https://t.co/e0Hz6g7zL2 https://t.co/0MioyEACpr" / X
![Simplifying Paperwork and Increasing Patient Access to Oncology Compassionate Use Therapeutics - Medical Documentation Software, Clinical Documentation Improvement, CDI Clinical Documentation Improvement, CDI Program, Insight Simplifying Paperwork and Increasing Patient Access to Oncology Compassionate Use Therapeutics - Medical Documentation Software, Clinical Documentation Improvement, CDI Clinical Documentation Improvement, CDI Program, Insight](https://hiteks.com/wp-content/uploads/2020/02/hiteksimage3.jpg)
Simplifying Paperwork and Increasing Patient Access to Oncology Compassionate Use Therapeutics - Medical Documentation Software, Clinical Documentation Improvement, CDI Clinical Documentation Improvement, CDI Program, Insight
![Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. - ScienceDirect Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359644620305092-gr1.jpg)
Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic. - ScienceDirect
![Initiating Early Access Programs: 5 Things to Consider :: executive insight | healthcare consultants Initiating Early Access Programs: 5 Things to Consider :: executive insight | healthcare consultants](https://www.executiveinsight.ch/application/files/thumbnails/image_sm/5715/2104/1179/initiatingearly_img1.png)
Initiating Early Access Programs: 5 Things to Consider :: executive insight | healthcare consultants
![Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try” - ScienceDirect Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try” - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2452302X17302917-gr1.jpg)
Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try” - ScienceDirect
![Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO](https://www.gao.gov/assets/extracts/b1ea33f945c9bdf9de3fd32fc2df69d8/rId13_image4.png)
Investigational New Drugs: FDA Has Taken Steps to Improve the Expanded Access Program but Should Further Clarify How Adverse Events Data Are Used | U.S. GAO
![Right to Try, expanded access use, Project Facilitate, and clinical trial reform - Annals of Oncology Right to Try, expanded access use, Project Facilitate, and clinical trial reform - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/4b70475c-c24e-41db-a32c-975e1ccdfb30/gr1.jpg)
Right to Try, expanded access use, Project Facilitate, and clinical trial reform - Annals of Oncology
![Expanded Access to Unapproved Drugs, Biologics, or Devices | Human Research Protection Office (HRPO) | University of Pittsburgh Expanded Access to Unapproved Drugs, Biologics, or Devices | Human Research Protection Office (HRPO) | University of Pittsburgh](https://www.hrpo.pitt.edu/sites/default/files/expanded_access_0.jpg)
Expanded Access to Unapproved Drugs, Biologics, or Devices | Human Research Protection Office (HRPO) | University of Pittsburgh
![Expanded Access Software — MedaSystems Collaborative Software for Access to Investigational Medicine Expanded Access Software — MedaSystems Collaborative Software for Access to Investigational Medicine](https://images.squarespace-cdn.com/content/v1/605e73530c9ba42c48529da1/bd4b2f22-15d0-4d6c-bf71-88eb62e352cd/diagram.png)